Ionetix Corporation is a radiopharmaceutical end to end solutions provider for cardiac PET.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/15/2023 | Series F | $47.29MM | $xx.xx | $20.09B | POINT Biopharma Global | |
Price per Share
$xx.xx
Shares Outstanding
33,777,262
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
POINT Biopharma Global
|
||||||
04/15/2016 | Series E | $25.39MM | $xx.xx | $11.55B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
22,671,428
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
06/08/2015 | Series D | $4.1MM | $xx.xx | $6.42B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,100,799
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
01/25/2013 | Series C | $4.25MM | $xx.xx | $5.27B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
07/11/2011 | Series B | $1.58MM | $xx.xx | $1.19B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,500,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
11/05/2010 | Series A | $644,999.93 | $xx.xx | $215MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
12,285,713
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|